The Market Impacts Of Pharmaceutical Product Patents In Developing Countries: Evidence From India
Mark Duggan,
Craig Garthwaite () and
Aparajita Goyal
Additional contact information
Craig Garthwaite: Northwestern University
No 14-005, Discussion Papers from Stanford Institute for Economic Policy Research
Abstract:
In 2005, as the result of a World Trade Organization mandate, India began to implement product patents for pharmaceuticals that were compliant with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). We combine pharmaceutical product sales data for India with a newly gathered dataset of molecule-linked patents issued by the Indian patent office. Exploiting variation in the timing of patent decisions, we estimate that a molecule receiving a patent experienced an average price increase of just 3-6 percent with larger increases for more recently developed molecules and for those produced by just one firm when the patent system began. Our results also show little impact on quantities sold or on the number of pharmaceutical firms operating in the market.
Date: 2014-10
New Economics Papers: this item is included in nep-com, nep-ino, nep-ipr and nep-pr~
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)
Downloads: (external link)
http://www-siepr.stanford.edu/repec/sip/14-005.pdf (application/pdf)
Related works:
Journal Article: The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India (2016) 
Working Paper: The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India (2014) 
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:sip:dpaper:14-005
Access Statistics for this paper
More papers in Discussion Papers from Stanford Institute for Economic Policy Research Contact information at EDIRC.
Bibliographic data for series maintained by Anne Shor ( this e-mail address is bad, please contact ).